Ahead of Earnings: Tilray Brands, Accolade, and AngioDynamics in the Spotlight
- September 30th, 2023
- 670 views
Some of the companies expected to report financial results on Wednesday, October 4, are:
Tilray Brands, Inc. (Nasdaq: TLRY), a company in the cannabis industry, is scheduled to release its first-quarter fiscal 2024 financial results before the market opens.
Analysts are forecasting a loss of $0.05 per share on revenue of $174 million.
On Friday, $TLRY closed at $2.39, up $0.04 (+1.70%).
Accolade, Inc. (Nasdaq: ACCD), a provider of personalized healthcare solutions, will unveil its fiscal second-quarter 2024 financial results after the market closes.
The consensus estimate points to a loss of $0.54 per share, accompanied by revenue reaching $94.09 million.
$ACCD closed at $10.58 on Friday, reflecting a decrease of $0.18 (-1.67%).
AngioDynamics, Inc. (Nasdaq: ANGO), a medical device company, is set to report financial results for the first quarter of fiscal year 2024 before the market opens.
Analysts expect a loss of $0.13 per share on revenue of $77.69 million.
On Friday, $ANGO closed at $7.31, down $0.01 (-0.14%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Countdown to Earnings: Nutanix, CrowdStrike, and Synopsys on Deck
August 23rd, 2026Investors Eye Semtech, Intuit, and nCino as Earnings Loom
August 22nd, 2026FTC Files Amicus Brief to Protect Competition in Biologic Drug Markets
August 21st, 2026
Member Login